Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial.
作者:
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);女(雌)性(Female);基因剂量(Gene Dosage);基因重排(Gene Rearrangement);基因, bcl-2(Genes, bcl-2);人类(Humans);免疫球蛋白重链(Immunoglobulin Heavy Chains);淋巴瘤, 滤泡性(Lymphoma, Follicular);男(雄)性(Male);中年人(Middle Aged);肿瘤, 残余(Neoplasm, Residual);预后(Prognosis);ROC曲线(ROC Curve);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1158/1078-0432.CCR-14-0407
PMID
25316810
发布时间
2014-12-16
- 浏览38

Clinical cancer research
6398-405页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文